top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Cancer Immunology
Cancer Immunology
Autore Subramanian Subree
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (316 p.)
Soggetto topico Medicine
Soggetto non controllato NKG2D
CAR T
IL-7
prostate cancer
cell therapy
CD19-CAR-T
B cell aplasia
KIR
PD-1
inhibitory CAR
tumor-infiltrating lymphocytes
tumor microenvironment
immunotherapy
NK cells
cancer stem cells (CSCs)
antibody-dependent cellular cytotoxicity (ADCC)
differentiation
cytotoxicity
IFN-γ
osteoclasts
MICA/B mAb
DNA methylation
RNA methylation
S-adenosylmethionine (SAM)
cancer
innate immunity
adaptive immunity
T cells
m6A
PD-L1
resistance
immune checkpoints
cancer vaccine
combination immunotherapy
TCR diversity
organ transplantation
carcinoma
epidemiologic studies
immunosuppression
CTLA-4
Treg cells
immune checkpoint inhibitors
CD28
antigen-presenting cells
IL15
colon cancer
melanoma
uveal
BAP1
anti-PD-1
anti-CTLA-4
TIL
classical and endemic Kaposi Sarcoma
systemic treatment
multi-state modelling
treatment free interval
chemotherapy
interferon
triple negative breast cancer
immunomodulation
bispecific antibody
sortase A
chemo-enzymatic approach
anti-CD20 antibody
Fab
BiFab
colorectal cancer
dendritic cells
Atypical Chemokine Receptor 4 (ACKR4)
T-cell priming
immune checkpoint blockade
primary liver cancer
kynurenine pathway
immune evasion
indoleamine 2,3 dioxygenase 1
tryptophan 2,3 dioxygenase 2
IDO inhibitor
antigen presenting cells
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557349203321
Subramanian Subree  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Nanomedicine
Cancer Nanomedicine
Autore Hoskins Clare
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (510 p.)
Soggetto topico Technology: general issues
Soggetto non controllato antibody drug conjugate (ADC)
PD-L1
tumor spheroid disruption
immune modulation
doxorubicin
graphene oxide
adsorption
cathepsin D
cathepsin L
anti-metastatic enzyme cancer therapy
nanoparticles
targeted delivery system
siRNA
osteopontin
mammary carcinoma
mesenchymal stem cells (MSCs)
TAT peptide
PLGA
paclitaxel
nano-engineered MSCs
orthotopic lung tumor model
intracranial glioma
immunotherapy
CPMV
viral nanoparticles
in situ vaccine
albumin nanoparticles
microbubble
ultrasound
theranostics
hepatocellular carcinoma
VX2 tumor
intra-arterial chemotherapy
lung cancer
nanomedicine
clinical status
cancer therapy
breast cancer
cell signaling
active targeting
passive targeting
EPR effect
oncogenes
nanoparticle
drug delivery
ligand
tumor targeting
biodistribution
Mesoporous silica nanoparticle
drug delivery system
target treatment
lanthanide metal
hyaluronic acid
hyaluronidase
drug combination
everolimus
dual-targeting
magnetic nanoparticles
monoclonal antibodies
nanostructured lipid carrier
platelet membrane
biomimicry
plasmonic photothermal therapy
gold nanorods
surgery
bleeding
dogs
cats
stimuli-responsive
DOX
SN38
CSCs
single-walled carbon nanotubes
chirality separation
NASH
drug-gene delivery
near IR hyperspectral imaging
plasmonics
copper
VEGF
glioblastoma
differentiated neuroblastoma
peptidomimetics
real-time quantitative polymerase chain reaction (qPCR)
actin
combinatorial therapy
anticancer and antibacterial activity
temoporfin
drug-in-cyclodextrin-in-liposome
hybrid nanoparticles
multicellular tumor spheroids
cyclodextrins
photodynamic therapy article
yet reasonably common within the subject discipline
antitumor strategy
biomimetic core–shell nanoparticles
NK cell-derived exosomes
folate receptor
albumin nanoparticle
microfluidic
cabazitaxel
polydopamine nanoparticles
size
cytotoxicity
iron affinity
FA-DABA-SMA
self-assembly
oncogenic proteins
intracellular disruption
folic receptor alpha
pancreatic cancer
parvifloron D
albumin
erlotinib
photodynamic therapy
lipid nanoparticles
tumor vectorization
verteporfin
ovarian carcinomatosis
spheroids
integrin
RGD peptide
cancer diagnosis
radiotherapy
hyperthermia therapy
biomimetic
nanocarrier
membrane-wrapped
cancer
targeted delivery
photothermal therapy
imaging
cancer nanomedicine
tumor microenvironment
nano–bio interactions
clinical translation
magnetic nanowires
magnetic hyperthermia
magnetic actuation
magnetic drug targeting
titanate nanotubes
gold nanoparticles
vectorization
colloidal stability
docetaxel
prostate cancer
mangiferin
anti-topoisomerase activity
extracellular vesicles
exosomes
chemico-physical functionalization
loading
translational medicine
nanotechnology: bioengineering
anacardic acid
mitoxantrone
targeted drug delivery
liposomes
melanoma
apoptosis
ascorbic acid
angiogenesis
epithelial-to-mesenchymal transition
hypoxia
immunosuppression
metabolism
nanotherapeutics
tumour microenvironment
DNA origami
liposome
remote loading
acute toxicity
organoids
magnetic silica-coated iron oxide nanochains
photothermal treatment
hyperthermia
collagen
cellular microenvironment
lymphadenectomy
magnetometer
sentinel lymph node dissection
SPION
superparamagnetic iron oxide nanoparticles
Vδ2 T cells
zoledronic acid
polymeric nanoconstruct
anti-tumor immunity
colorectal carcinoma
β-cyclodextrin nanosponges
BALB-neuT mice
brain tumours
glioma
blood brain barrier
polymeric nanoparticles
PEGylation
dioleoylphosphatidylethanolamine
poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer
folate
oxidation-sensitive release
cellular interaction
in vitro anti-cancer activity
triple negative breast cancer
organotin
mesoporous silica nanoparticles
MDA-MB-231
theranostic nanomaterials
nanobiotechnology
molecular imaging
nanosystems
nanomicelles
ovarian cancer
tumour targeting
chemotherapeutics
riboflavin
vitamin B2
nanomedicines
secondary structure
mixed micelle
pH responsive
targeted therapy
anti-cancer
shear stress
flow
in vitro
therapeutics
diagnostics
Immunotherapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557114703321
Hoskins Clare  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Molecular Pathways in Cancers
Molecular Pathways in Cancers
Autore Cristóbal Ion
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (284 p.)
Soggetto topico Medicine
Oncology
Soggetto non controllato actin cytoskeletal reorganization
breast cancer
CD99 agonist
EGFR dimerization
endocytosis
FAK dephosphorylation
PTPN12
Rac1
RhoA
tripeptide
OMD
PRELP
tumor suppression gene
bladder cancer initiation
tight junction
partial EMT
tousled-like kinase (TLK)
NIMA-related kinase 1 (NEK1)
yes-associated protein 1 (YAP1)
thioridazine (THD)
MS-determined phosphopeptides
human immunodeficiency virus type 1
epithelial cells
carcinogenicity
oxidative stress
reactive oxygen species
gp120
Tat
Nef
matrix protein p17
reverse transcriptase
mitochondria
metastasis
OXPHOS
cancer
Warburg effect
cancer therapeutics
myeloproliferative neoplasms
signaling pathways
JAK2
CALR
MPL
TPOR
DUSP1
MAPK
Snail
prostate cancer
migration and invasion
patient survival
biomarkers
pBRD4
SET
PP2A
prognosis
triple negative breast cancer
resistance
anti-receptor therapy
trastuzumab
PI3K
mTOR
TAK-228
epigenetic
methylation
acetylation
non-coding RNA
small-cell lung cancer
triple-negative breast cancer
pancreatic ductal adenocarcinoma
glioblastoma
metastatic melanoma
advanced ovarian cancer
hepatocellular carcinoma
immune evasion
immunotherapy
immune checkpoint inhibitors
oncogenic signaling pathway
molecular targeted agents
genome
epigenome
tumor immune microenvironment
ovarian cancer
adaptive immunity
innate immunity
complement system
cancer immunology
tumor microenvironment
splicing pathway
luminal breast cancer
BET inhibitors
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566473703321
Cristóbal Ion  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Plant Therapeutics
Plant Therapeutics
Autore Cheng Juei-Tang
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (280 p.)
Soggetto topico Medicine
Pharmacology
Soggetto non controllato safflower
hydroxysafflor yellow A
safflower yellow A
flavonoid
platelet aggregation
vescalagin
methylglyoxal
inflammation
antioxidant
insulin secretion
traditional medicine
hypoglycemic plants
Eryngium longifolium
Alsophila firma
glucose 6-phosphatase
fructose 1,6-bisphosphatase
Lycium shawii
Anabasis articulata
Rumex vesicarius
Zilla spinosa
anticancer
antimicrobial
biogenetic interrelationship
flavonoid contents
trace elements
human tumor cell lines
cytotoxic effect
plant extracts
Acalypha monostachya
Lindera obtusiloba
apolipoprotein E-deficient mice
atherosclerosis
endothelium
black bean soybean sauce
by-product
functional supplements
Moringa oleifera
anti-aging
fibrosis
kidney disease
Gan-Mai-Da-Zao
depression
brain-derived neurotrophic factor
serotonin transporter
unpredictable chronic mild stress
Acalypha arvensis
ellagitannin
corilagin
Staphylococcus aureus
flavonoids
antibacterial
Alzheimer's disease
amyloid β
immunomagnetic reduction
Drosophila melanogaster
water extract of fermented rice bran
non-alcoholic fatty liver disease
high-fat diet
aged rat
Salvia haematodes
rapid solid-liquid dynamic extraction (RSLDE)
extractor Naviglio®
Soxhlet apparatus
medium pressure liquid chromatography (MPLC)
antioxidant potential
Inga jinicuil
phytochemical profile
HPLC-PDA
GC-MS
anti-inflammatory
fast dissolving films
yeast β-glucan
bilberry juice
diabetes
herbal medicine
bioactive derivative
triple negative breast cancer
Wnt/β-catenin
anti-cancer
ISBN 3-0365-5955-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910637778703321
Cheng Juei-Tang  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of Medical Imaging in Cancers . Volume 1
Role of Medical Imaging in Cancers . Volume 1
Autore Fanti Stefano
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (312 pages)
Soggetto topico Medicine
Soggetto non controllato positron emission tomography
head and neck neoplasms
neovascularization
pathologic
PET/CT
urothelial carcinoma
bladder cancer
upper tract urothelial carcinoma
survival
PET
PSMA
prostate
DCFPyL
DCFBC
PSMA-1007
ovarian cancer
relapse
SUVmax
targeted therapy
prognosis
soft tissue sarcoma (STS)
pazopanib
dynamic 18F-FDG PET/CT
SUV
two-tissue compartment model
magnetic resonance imaging
machine learning
diffusion
perfusion
texture analysis
squamous cell carcinoma of the head and neck
diffusion-weighted imaging
malignant pleural mesothelioma
pleural dissemination
empyema
pleural effusion
mCRPC
SPECT/CT
Computer-assisted diagnosis
XOFIGO
Therapy response assessment
circulating miRNAs
breast cancer
imaging parameters
PET/MRI
biomarkers
triple negative breast cancer
VCAM-1
SPECT imaging
sdAbs
Hounsfield unit
computed tomography
adipose tissue
precision oncology
FDG-PET/CT
PERCIST
metastatic breast cancer
prostate cancer
18F-FACBC
recurrence
meta-analysis
review
meningioma
somatostatin receptor
neuroimaging
radionuclide therapy
breast
imaging
marker
radiomics
Yin Yang 1
PDAC
Mesothelin
noninvasive imaging
receptor status
molecular imaging
nuclear medicine
guidelines
overutilization
epistemology
consensus
mantle cell lymphoma
18F-FDG PET/CT
Deauville criteria
Radium-223
FDG
castrate resistant prostate cancer
programmed cell death 1 receptor
diagnostic imaging
CTLA-4 Antigen
Immunotherapy
Adoptive
radioactive tracers
radionuclide imaging
CD8-Positive T-Lymphocytes
PI-RADS
diffusion kurtosis imaging
dynamic contrast-enhanced magnetic resonance imaging
68Gallium-PSMA PET/CT
prostate-specific-antigen
PSA kinetics thresholds
biochemical recurrence
optimal cutoff level
non-small-cell lung cancer
circulating tumor cells
immunotherapy
response to treatment
head and neck cancer
HPV
EBV
p16
Molecular imaging
miRNA expression
radiogenomics
radiomic
diagnosis
biomarker
glioblastoma
radiation therapy
MRI
diffusion tensor imaging
Hodgkin lymphoma
diffuse large B-cell lymphoma
staging
response assessment
locally advanced cervical cancer
concurrent chemoradiotherapy
treatment response
follow up
cystic tumor
International Consensus Guidelines
intraductal papillary mucinous neoplasms
pancreatic neoplasms
PD-1
PD-L1
response to therapy
NSCLC
positron-emission tomography
single-photon emission computed tomography
immune checkpoint inhibitors
gold nanoparticle
heat shock protein 70
spectral-CT
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557432103321
Fanti Stefano  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of Medical Imaging in Cancers . Volume 2
Role of Medical Imaging in Cancers . Volume 2
Autore Fanti Stefano
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (228 p.)
Soggetto topico Medicine
Soggetto non controllato positron emission tomography
head and neck neoplasms
neovascularization
pathologic
PET/CT
urothelial carcinoma
bladder cancer
upper tract urothelial carcinoma
survival
PET
PSMA
prostate
DCFPyL
DCFBC
PSMA-1007
ovarian cancer
relapse
SUVmax
targeted therapy
prognosis
soft tissue sarcoma (STS)
pazopanib
dynamic 18F-FDG PET/CT
SUV
two-tissue compartment model
magnetic resonance imaging
machine learning
diffusion
perfusion
texture analysis
squamous cell carcinoma of the head and neck
diffusion-weighted imaging
malignant pleural mesothelioma
pleural dissemination
empyema
pleural effusion
mCRPC
SPECT/CT
Computer-assisted diagnosis
XOFIGO
Therapy response assessment
circulating miRNAs
breast cancer
imaging parameters
PET/MRI
biomarkers
triple negative breast cancer
VCAM-1
SPECT imaging
sdAbs
Hounsfield unit
computed tomography
adipose tissue
precision oncology
FDG-PET/CT
PERCIST
metastatic breast cancer
prostate cancer
18F-FACBC
recurrence
meta-analysis
review
meningioma
somatostatin receptor
neuroimaging
radionuclide therapy
breast
imaging
marker
radiomics
Yin Yang 1
PDAC
Mesothelin
noninvasive imaging
receptor status
molecular imaging
nuclear medicine
guidelines
overutilization
epistemology
consensus
mantle cell lymphoma
18F-FDG PET/CT
Deauville criteria
Radium-223
FDG
castrate resistant prostate cancer
programmed cell death 1 receptor
diagnostic imaging
CTLA-4 Antigen
Immunotherapy
Adoptive
radioactive tracers
radionuclide imaging
CD8-Positive T-Lymphocytes
PI-RADS
diffusion kurtosis imaging
dynamic contrast-enhanced magnetic resonance imaging
68Gallium-PSMA PET/CT
prostate-specific-antigen
PSA kinetics thresholds
biochemical recurrence
optimal cutoff level
non-small-cell lung cancer
circulating tumor cells
immunotherapy
response to treatment
head and neck cancer
HPV
EBV
p16
Molecular imaging
miRNA expression
radiogenomics
radiomic
diagnosis
biomarker
glioblastoma
radiation therapy
MRI
diffusion tensor imaging
Hodgkin lymphoma
diffuse large B-cell lymphoma
staging
response assessment
locally advanced cervical cancer
concurrent chemoradiotherapy
treatment response
follow up
cystic tumor
International Consensus Guidelines
intraductal papillary mucinous neoplasms
pancreatic neoplasms
PD-1
PD-L1
response to therapy
NSCLC
positron-emission tomography
single-photon emission computed tomography
immune checkpoint inhibitors
gold nanoparticle
heat shock protein 70
spectral-CT
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557309503321
Fanti Stefano  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui